Psychological trauma increases the risk of developing anxiety, depression and drug addiction. The endocannabinoid system, which comprises endogenous lipid-derived cannabinoid agonists and their G protein-coupled cannabinoid (CB) receptors, has been implicated in the modulation of stress responses, but its role in the response to traumatic events is unclear. In initial studies, I found that rats exposed to a life- threatening stimulus, the red fox pheromone TMT, display marked changes in the mobilization of the endocannabinoid, 2-arachidonoyl-sn-glycerol (2-AG) in select regions of the brain. These effects last for at least 7 days after the stress has occurred. I also found that pharmacological inhibition of monoacylglycerol lipase (MGL) - a lipid hydrolase that degrades 2-AG in presynaptic terminals - increases brain 2-AG levels and suppresses the anxiety-like behavior triggered by TMT. My findings suggest that (a) predator threat produces long-term changes in endocannabinoid 2-AG-mediated signaling in the brain;and (b) pharmacological interventions targeting MGL may provide a useful therapeutic strategy for the treatment of chronic brain disorders initiated by trauma. I will test these hypotheses with two specific aims.
Aim 1 : Effects of predator stress on brain 2-AG-mediated signaling. I will use a combination of molecular, biochemical and morphological approaches to investigate the impact of TMT on the expression of proteins involved in brain 2-AG-mediated signaling. I will target enzymes involved in 2-AG formation and degradation, as well as cannabinoid receptors. I will survey key regions of the brain implicated in stress control and investigate the time-course of the response over a period of 8 weeks. Based on my preliminary data, I expect that predator threat will cause long-lasting alterations in brain 2-AG signaling.
Aim 2 : Effects of MGL inhibition on chronic predator stress-induced anxiety. I will (a) characterize the dose-response of the anxiolytic-like effects of the potent and selective MGL inhibitor, JZL-184, verifying that such effects correlate with blockade of MGL activity;(b) determine, using pharmacological antagonists, if CB1 and CB2 cannabinoid receptors are involved in the response to JZL-184;(c) define the time window during which MGL is most effective in suppressing TMT- induced responses (e.g. immediately after trauma or later on, when trauma-related changes have been established);and, finally, (d) confirm the results obtained with JZL-184 using shRNA-mediated suppression of MGL expression. My hypothesis predicts that pharmacological and genetic interference with 2-AG availability will prevent the development of anxiety-like behavior elicited by predator threat. If successful, the proposed studies will demonstrate that acute life-threatening stress alters 2-AG signaling in specific regions of the brain, which in turn regulates the long-term response to the stressful event. My experiments will further suggest that pharmacological strategies aimed at enhancing 2-AG-mediated endocannabinoid signaling may offer a novel approach to the treatment of trauma-induced disorders such as anxiety, depression and drug addiction.

Public Health Relevance

The brain naturally produces marijuana-like molecules called endocannabinoids, which are involved in the regulation of stress and anxiety. Building upon my preliminary findings that an acute traumatic event can result in long-lasting anxiety and significant changes in endocannabinoid regulation, the proposed research will test the hypothesis that pharmacological modulation of the endocannabinoid system might prevent the generation of anxiety states following a life-threatening trauma. This work is directly relevant to public health as it would advance our understanding of cellular processes underlying anxiety disorders and provide new insights on post-traumatic stress disorder, a highly prevalent and debilitating condition.

National Institute of Health (NIH)
Predoctoral Individual National Research Service Award (F31)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Babecki, Beth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Irvine
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code